Immune Globulin Screening Pilot (IGSP)

This 2016 pilot study was initiated in Ontario by the Immune Globulin Advisory Panel, in collaboration with the Ontario Ministry of Health, to address several critical issues related to the use of immune globulin (IG) in hospitals, particularly within the neurology specialty. Its purpose was to test whether a more rigorous screening process could achieve the outlined goals and provide a model for broader application.

English Report

French Report